Casdatifan
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Casdatifan, covering 2025-11-13 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 3]